2007's most comprehensive QT & Safety Pharmacology Strategy Congress takes place in just under two weeks!

Posted:
11
October 2007

The pre-conference workshop will be hosted by Richmond Pharmacology; the leading Trial Centre and ECG Core Lab for conducting QTc studies. The workshop will address 'Key Issues and Best Practice in Conducting a Definitive Thorough QTc Study'.Included in the line up of speakers will be Prof. A. J. Camm, Chairman of the Department of Cardiovascular Sciences and the Division of Cardiological Sciences, St George's Hospital, UK. This offers you the unique opportunity to discuss the latest developments in the design and conduct of QTc studies. Please click the following link to view the agenda for the meeting.As hosts of the QTc Workshop we are pleased to offer the Workshop at a discounted rate to our clients. Alternatively, we are able to also offer both the workshop and main conference for the reduced price of £250. For further information contact Charlotte Vowden at c.vowden@richmondpharmacology.com.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more